Evidence map›Paper›PMID 36567397›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2023

Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organization.

Marija Dinevska, Samuel S Widodo, Liam Furst, Lucero Cuzcano, Yitong Fang, Stefano Mangiola, Paul J Neeson, Phillip K Darcy, Robert G Ramsay, Ryan Hutchinson and 4 more

Abstract read
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Immune Subtypes and Survival in Patients with Primary Glioma.medRxiv : the preprint server for health sciences · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Marija Dinevska *Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.
Samuel S Widodo *Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.
Liam FurstDepartment of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia.
Lucero CuzcanoDepartment of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia.
Yitong FangDepartment of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia.
Stefano MangiolaBioinformatics Division, The Walter and Eliza Hall Institute, Parkville, VIC, Australia.
Paul J NeesonCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Phillip K DarcyCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Robert G RamsayCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Ryan HutchinsonDepartment of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia.
Fabienne MacKayDepartment of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia.
Michael ChristieDepartment of Anatomical Pathology, Royal Melbourne Hospital, Parkville, VIC, Australia.
Stanley S StylliDepartment of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.
Theo MantamadiotisDepartment of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia. theom@unimelb.edu.au.ORCID http://orcid.org/0000-0003-3971-5380
The University of Melbourne · AUThe Royal Melbourne Hospital · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

Cass Foundation 6236 and 7941Department of Surgery (RMH) and School of Biomedical Sciences translational grant T.M. and F.M.
6 · The paper itself

Abstract

purposeTumor cells thrive by adapting to the signals in their microenvironment. To adapt, cancer cells activate signaling and transcriptional programs and migrate to establish micro-niches, in response to signals from neighboring cells and non-cellular stromal factors. Understanding how the tumor microenvironment evolves during disease progression is crucial to deciphering the mechanisms underlying the functional behavior of cancer cells.

methodsMultiplex immunohistochemistry, spatial analysis and histological dyes were used to identify and measure immune cell infiltration, cell signal activation and extracellular matrix deposition in low-grade, high-grade astrocytoma and glioblastoma.

resultsWe show that lower grade astrocytoma tissue is largely devoid of infiltrating immune cells and extracellular matrix proteins, while high-grade astrocytoma exhibits abundant immune cell infiltration, activation, and extensive tissue remodeling. Spatial analysis shows that most T-cells are restricted to perivascular regions, but bone marrow-derived macrophages penetrate deep into neoplastic cell-rich regions. The tumor microenvironment is characterized by heterogeneous PI3K, MAPK and CREB signaling, with specific signaling profiles correlating with distinct pathological hallmarks, including angiogenesis, tumor cell density and regions where neoplastic cells border the extracellular matrix. Our results also show that tissue remodeling is important in regulating the architecture of the tumor microenvironment during tumor progression.

conclusionThe tumor microenvironment in malignant astrocytoma, exhibits changes in cell composition, cell signaling activation and extracellular matrix deposition during disease development and that targeting the extracellular matrix, as well as cell signaling activation will be critical to designing personalized therapy.

Indexed as

AstrocytomaBrain NeoplasmsGliomaExtracellular MatrixHumansSignal TransductionTumor MicroenvironmentAstrocytomaCell signalingExtracellular matrixGlioblastomaGliomaMacrophagesT-cellsTissue remodelingTumor microenvironment

Identifiers

PMID36567397
PMCPMC12974717
OpenAlexW4312194876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.